ACP

Status: Approved
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Coronary Artery Disease; Coronary Disease; Myocardial Ischemia Phase 2 ClinicalTrials
Lymphoma; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse Phase 3 ClinicalTrials
Glomerulonephritis, IGA; Kidney Diseases Phase 4 ClinicalTrials
CONTENTS